This week's Scientific American: A new, easy-to-store COVID-19 vaccine authorized last week by India’s drug regulation agency holds the potential to significantly advance global vaccine equity, write Peter J. Hotez and Maria Elena Bottazzi, both at Baylor College of Medicine and the Texas Children’s Hospital Center for Vaccine Development. The recombinant protein vaccine, called CORBEVAX, soon will overtake COVID-19 vaccine doses contributed by the U.S. or any other G7 country, the authors write.


Robin Lloyd
robinlloyd99